Hyperglycaemia up-regulates placental growth factor (PlGF) expression and secretion in endothelial cells via suppression of PI3 kinase-Akt signalling and activation of FOXO1
Abstract Placenta growth factor (PlGF) is a pro-inflammatory angiogenic mediator that promotes many pathologies including diabetic complications and atherosclerosis. Widespread endothelial dysfunction precedes the onset of these conditions. As very little is known of the mechanism(s) controlling PlG...
Guardado en:
Autores principales: | Samir Sissaoui, Stuart Egginton, Ling Ting, Asif Ahmed, Peter W. Hewett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e779ba4e943f492091ba658714e569c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Anna Maria Nuzzo, et al.
Publicado: (2021) -
Genetics of PlGF plasma levels highlights a role of its receptors and supports the link between angiogenesis and immunity
por: Daniela Ruggiero, et al.
Publicado: (2021) -
Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF
por: Xinyuan Zhang, et al.
Publicado: (2021) -
Prenatal diagnosis of mosaic trisomy 16 by amniocentesis in a pregnancy associated with abnormal first-trimester screening result (low PAPP-A and low PlGF), intrauterine growth restriction and a favorable outcome
por: Chih-Ping Chen, et al.
Publicado: (2021) -
Hyperglycaemia in criticaly ill patients
por: Tatiana Valer'evna Klypa, et al.
Publicado: (2015)